Lawrence Bruno, Chairman and CEO at Core Laboratories Inc. /DE/ (CLB), bought 5,000 shares at $10.78 ($54K) on 2026-07-31, disclosed to the SEC on 2026-08-04.
Chairman and CEO Lawrence Bruno purchased 5,000 shares for $53,900, marking the largest purchase of his career and reversing a 12-consecutive-share selling streak. This rare insider buying at a 52-week low could signal confidence in the company's valuation after a significant selloff.
CLB is trading at $11.20, down 18.28% over the last 90 days and 44.99% from its 52-week high of $20.36, despite a 4.67% gain in the past five days.
1) Q2 2026 earnings on July 31, 2026, where EPS beat estimates by 26.9% despite a 4.3% revenue decline; 2) Q3 2026 earnings on October 29, 2026; 3) A cluster of 12 consecutive insider sells prior to this purchase, which often precedes a reversal.
1) The stock is down 47.1% over the last six months; 2) Recent news highlights geopolitical headwinds and falling earnings, which may pressure the stock further.
Nothing distinguishes this filing.